Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)
Renub Research
September 20, 2010 89 Pages - SKU: RNBR2817065
|
|
Countries covered: Global
Our new report “Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)” examines the commercial prospects for In Vitro Diagnostics (IVD) in the global healthcare market. The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care Testing, Microbiology, Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market.
The report has been researched at source globally and features latest available data covering:
- Ten IVD sub-segment past, present and future forecast market share
- Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market
- Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009
- Top ten Merger & Acquisition deals in 2008 and 2009
- Licensing by ten IVD players
- Review of International In Vitro Diagnostics Regulations
- Key drivers of growth in the global IVD market
- Key challenges faces by IVD market in the coming years
Research Highlights
- Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014
- Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009
- Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014
- In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share
- After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009
- Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009
- 51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007
- 18 In-Licensing deals were announced in 2008 compared to 27 in 2007
- By 2009 there were 12 countries with more than 10 Million people aged 60 or over
- Third Wave Technologies (TWT) was acquired by Hologic to grow its existing women’s health and diagnostics business was the best deal in 2008
- In 2009, Beckman Coulter acquired the diagnostic systems part of Olympus’s life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.
Key Players Analyzed
This section covers the key facts about the major players in In Vitro Diagnostics market. The key players analyzed in this section are - Roche, Sysmex, Biomerieux, OCD(J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens.
Data Sources
Information and data in this report has been collected from various printable and non-printable sources like Trade Journals, White papers, Online paid databases, News websites, Government Agencies, Magazines, Newspapers and Trade associations.
|
- 1. Executive Summary
- 2. Global In Vitro Diagnostics Market & Future Forecast
- 2.1 Global - In Vitro Diagnostics Market Share & Future Forecast
- 2.2 Global IVD Market, Market Share by Company
- 3. In Vitro Diagnostics Market Segment - Past, Present & Future Forecast
- 3.1 Molecular Diagnostics
- 3.2 Clinical Chemistry
- 3.3 Hematology
- 3.4 Immunoassay
- 3.5 Point of Care Testing
- 3.6 Microbiology
- 3.7 Histology/Cytology
- 3.8 Flow Cytometry
- 3.9 Blood Screening Typing
- 3.10 Coagulation
- 4. Geographical Segmentation
- 4.1 USA - In Vitro Diagnostics Market
- 4.2 Japan - In Vitro Diagnostics Market
- 4.3 Europe - In Vitro Diagnostics Market
- 4.4 India - In Vitro Diagnostics Market
- 4.5 China - In Vitro Diagnostics Market
- 4.6 Taiwan - In Vitro Diagnostics Market
- 5. Merger & Acquisitions
- 5.1 Mergers & Acquisitions Deals in the IVD Sector, 2009
- 5.2 Number of All Mergers & Acquisitions Deals in the IVD Sector, (2004 - 2008)
- 5.3 Top Ten Mergers & Acquisitions Deals in the IVD Sector, 2008
- 5.4 Value of Disclosed Mergers & Acquisitions Deals in the IVD Sector, (2004 - 2008)
- 6. Licensing By Ten IVD Majors
- 6.1 Number of In-Licensing Deals Announced, (2004 - 2008)
- 6.2 Number of In-Licensing Deals announced in 2008 by Ten IVD Majors
- 6.3 Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies
- 6.4 In-Licensing Deals Announced in 2008 by Ten IVD Players
- 7. A Review of International IVD Regulations
- 7.1 GHTF and AHWP: Elements for a Regulatory System
- 7.2 More Emphasis on Environmental Topics
- 7.2.1 Instructions for Use and Other Labeling
- 7.3 Auditing: A Tool for Improving Processes
- 7.3.1 More Regulated Countries
- 7.4 Future Leadership and Outlook for the Next 15 Years
- 8. Key Drivers of Growth in Global IVD Market
- 8.1 Aging of the population
- 8.1.1 Population Aged 60 or Over: World and Development Regions, 1950 - 2050
- 8.1.2 Old-Age Dependency Ratio: Major Areas, 2009 and 2050
- 8.2 Personalized Medicine - The Future
- 8.3 Continued Expansion of Point Of Care Including Self Testing
- 8.3.1 Future of Point of Care Testing - The ‘Worried Well’
- 8.3.2 Theranostics - Companion Diagnostics
- 8.3.3 Hub and Spoke
- 8.3.4 Education
- 8.4 Pharmacogenetic Testing and New Types of Genetic Disease Screening Tests
- 9. Key Challenges In the Global In Vitro Diagnostics Market
- 9.1 Regulatory and Reimbursement Issues
- 9.1.1 Coverage Policies
- 9.2 Manufacturing Obstacles in IVD Product Development
- 9.2.1 Rise in Point of Care (POC) Technologies
- 9.2.2 Avoiding Too Much, Too Soon
- 9.2.3 Closely Considering Materials and Environment
- 10. Key Players in the Global IVD Market
- 10.1 Abbott Laboratories
- 10.2 Roche
- 10.3 biomerieux
- 10.4 Beckman Coulter
- 10.5 BD (Becton, Dickinson and Company)
- 10.6 Sysmex
- 10.7 Siemens
- 10.8 Ortho Clinical Diagnostics
- List of Figures:
- Figure 2 1: Global - In Vitro Diagnostic Market (Billion US$), 2007 - 2009
- Figure 2 2: Global - Forecast for In Vitro Diagnostics Market (Billion US$), 2010 - 2014
- Figure 2 3: Global - Segments of In Vitro Diagnostics Market Share (Percent), 2007 - 2009
- Figure 2 4: Global - Forecast for Segments of In Vitro Diagnostics Market Share (Percent), 2010 - 2014
- Figure 2 5: Global - In Vitro Diagnostics Market Share of top 8 Companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) (Percent), 2009
- Figure 3 1: Global - Molecular Diagnostics Market (Billion US$), 2007 - 2009
- Figure 3 2: Global - Forecast for Molecular Diagnostics Market (Billion US$), 2010 - 2014
- Figure 3 3: Global - Clinical Chemistry Market (Billion US$), 2006 - 2009
- Figure 3 4: Global - Forecast for Clinical Chemistry Market (Billion US$), 2010 - 2014
- Figure 3 5: Global - Hematology Market (Billion US$), 2007 - 2009
- Figure 3 6: Global - Forecast for Hematology Market (Billion US$), 2010 - 2014
- Figure 3 7: Global - Immunoassay Market (Billion US$), 2006 - 2009
- Figure 3 8: Global - Forecast for Immunoassay Market (Billion US$), 2010 - 2014
- Figure 3 9: Global - Point of Care Testing Market (Billion US$), 2003, 2006 - 2009
- Figure 3 10: Global - Forecast for Point of Care Testing Market (Billion US$), 2010 - 2014
- Figure 3 11: Global - Microbiology Market (Billion US$), 2006 - 2009
- Figure 3 12: Global - Forecast for Microbiology Market (Billion US$), 2010 - 2014
- Figure 3 13: Global - Histology/Cytology Market (Billion US$), 2005 - 2009
- Figure 3 14: Global - Forecast for Histology/Cytology Market (Billion US$), 2010 - 2014
- Figure 3 15: Global - Flow Cytometry Market (Billion US$), 2007 - 2009
- Figure 3 16: Global - Forecast for Flow Cytometry Market (Billion US$), 2010 - 2014
- Figure 3 17: Global - Blood Screening Typing Market (Billion US$), 2006 - 2009
- Figure 3 18: Global - Forecast for Blood Screening Typing Market (Billion US$), 2010 - 2014
- Figure 3 19: Global - Coagulation Market (Billion US$), 2006 - 2009
- Figure 3 20: Global - Forecast for Coagulation Market (Billion US$), 2010 - 2014
- Figure 4 1: USA - In Vitro Diagnostics Market (Billion US$), 2002 - 2009
- Figure 4 2: USA - Forecast for In Vitro Diagnostics Market (Billion US$), 2010 - 2012
- Figure 4 3: Japan - In Vitro Diagnostics Market (Billion US$), 2002 - 2009
- Figure 4 4: Japan - Forecast for In Vitro Diagnostics Market (Billion US$), 2010 - 2012
- Figure 4 5: Europe - In Vitro Diagnostics Market (Billion US$), 2002 - 2009
- Figure 4 6: Europe - Forecast for In Vitro Diagnostics Market (Billion US$), 2010 - 2012
- Figure 4 7: India - In Vitro Diagnostics Market (Million US$), 1996 - 2009
- Figure 4 8: India - Forecast for In Vitro Diagnostics Market (Million US$), 2010 - 2012
- Figure 4 9: China - In Vitro Diagnostics Market (Million US$), 1995 - 2009
- Figure 4 10: China - Forecast for In Vitro Diagnostics Market (Million US$), 2010 - 2012
- Figure 4 11: Taiwan - In Vitro Diagnostics Market (Million US$), 2007 - 2009
- Figure 4 12: Taiwan - Forecast for In Vitro Diagnostics Market (Million US$), 2010 - 2012
- Figure 5 1: Global - Number of All Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2004 - 2008
- Figure 5 2: Global - Value of Disclosed Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector (Billion US$) 2004 - 2008
- Figure 6 1: Global - Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies 2004 - 2008
- Figure 6 2: Global - Number of In-Licensing Deals announced by Ten In Vitro Diagnostics Companies, 2008
- Figure 6 3: Global - Number of In-Licensing Deals by Ten In Vitro Diagnostics Companies, 2004 - 2008
- Figure 8 1: Global - Population Aged 60 or Over: World and Development Regions, 1950, 1975, 2009, 2025 & 2050
- Figure 8 2: Global - Old-Age Dependency Ratio: Major Areas, 2009 & 2050
- List of Table:
- Table 5 1: Global - Mergers & Acquisitions Deals in the In Vitro Diagnostics Sector, 2009
- Table 5 2: Global - Top Ten Mergers & Acquisitions Deals in In Vitro Diagnostics Sector (Million US$), 2008
- Table 6 1: Global - In-Licensing Deals Announced in 2008 by Ten IVD Players
- Table 8 1: Global - Population Aged 60 or Over, 65 or Over and 80 Or Over By Sex (Thousands): World, Major Areas and Regions, 2009
- Table 10 1: Abbott Laboratories - Key Financials (Million US$) 2007 - 2009
- Table 10 2: Roche - Key Financials (Million US$) 2007 - 2009
- Table 10 3: Biomerieux - Financials (Million US$) 2007 - 2009
- Table 10 4: Beckman Coulter - Financials (Million US$) 2007 - 2009
- Table 10 5: BD (Becton, Dickinson and Company) - Financials (Thousand US$) 2008 - 2009
- Table 10 6: Sysmex - Financials (Million Yen) 2007 - 2009
- Table 10 7: Siemens - Financials (Million Euros) 2008 - 2009
More Global Molecular Diagnostics Reports
In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers & Microbiology Culture) – Global Trends & Forecasts to 2016 by
MarketsandMarkets
The global in-vitro diagnostics (IVD) market was valued at $44 billion in 2011 and is expected to have a modest growth during the study period. ...
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...
2012 Global Molecular Diagnostics Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant ...
The 2012 Global Molecular Diagnostics Market: Facilities, Test Volumes, and Sales Forecasts by Country by
Venture Planning Group
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as ...
Genetic Testing by
Global Industry Analysts
This report analyzes the worldwide markets for Genetic Testing in US$ Million. The US market is analyzed by the following Segments: Prenatal and Newborn Genetic ...
See all reports like this >>
Share this report
Other tasks Related Markets Molecular Diagnostics Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|